| Keith Brian Elbourne, MD | |
|
6550 Main St., Suite 2000, Zachary, LA 70791-4033 | |
| (225) 658-1303 | |
| (225) 658-1304 |
| Full Name | Keith Brian Elbourne |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 6550 Main St., Zachary, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194742122 | NPI | - | NPPES |
| 1053074 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD.026232 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lane Regional Medical Center | Zachary, LA | Hospital |
| Womans Hospital | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Service District 1 Of East Baton Rouge Parish | 0941191902 | 29 |
News Archive
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
In the United States, one in every five households speaks a language other than English at home. Research has shown, as English language proficiency decreases, positive healthcare outcomes also decrease.
On average, about five percent of total cancer research funding is spent on investigating metastases (the spread of cancer cells around the body) in Europe, yet metastatic disease is the direct or indirect cause of 90 percent of all cancer deaths, according to an editorial in the European Journal of Cancer (EJC).
UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.
Researchers discovered a brain deficiency in people with schizophrenia that could lead to development of new drug therapies.
› Verified 9 days ago
| Entity Name | Hospital Service District #1 Of East Baton Rouge Parish |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962437681 PECOS PAC ID: 0941191902 Enrollment ID: O20040322000429 |
News Archive
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
In the United States, one in every five households speaks a language other than English at home. Research has shown, as English language proficiency decreases, positive healthcare outcomes also decrease.
On average, about five percent of total cancer research funding is spent on investigating metastases (the spread of cancer cells around the body) in Europe, yet metastatic disease is the direct or indirect cause of 90 percent of all cancer deaths, according to an editorial in the European Journal of Cancer (EJC).
UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.
Researchers discovered a brain deficiency in people with schizophrenia that could lead to development of new drug therapies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith Brian Elbourne, MD 2335 Church St Ste E, Zachary, LA 70791-2700 Ph: (225) 570-2489 | Keith Brian Elbourne, MD 6550 Main St., Suite 2000, Zachary, LA 70791-4033 Ph: (225) 658-1303 |
News Archive
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
In the United States, one in every five households speaks a language other than English at home. Research has shown, as English language proficiency decreases, positive healthcare outcomes also decrease.
On average, about five percent of total cancer research funding is spent on investigating metastases (the spread of cancer cells around the body) in Europe, yet metastatic disease is the direct or indirect cause of 90 percent of all cancer deaths, according to an editorial in the European Journal of Cancer (EJC).
UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.
Researchers discovered a brain deficiency in people with schizophrenia that could lead to development of new drug therapies.
› Verified 9 days ago
Dr. Jeanne Nicole Gautreaux, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6550 Main St, Suite 2000, Zachary, LA 70791 Phone: 225-235-9308 Fax: 225-658-1304 | |
Lydia Dee Lewis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4845 Main St, Suite D, Zachary, LA 70791 Phone: 225-761-5200 Fax: 225-754-5063 | |
Mrs. Samantha Bland-naquin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6550 Main St Ste 2000, Zachary, LA 70791 Phone: 225-658-1303 Fax: 225-658-1304 | |
Joshua Best, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6550 Main St, Suite 2000, Zachary, LA 70791 Phone: 225-658-1305 |